Visceral leishmaniasis in patients with lymphoma Case reports and review of the literature

被引:7
作者
Kalmi, Galith [1 ,2 ]
Vignon-Pennamen, Marie-Dominique [3 ]
Ram-Wolff, Caroline [1 ]
Battistella, Maxime [2 ,3 ,6 ]
Lafaurie, Mathieu [4 ]
Bouaziz, Jean-David [1 ,2 ,6 ]
Hamane, Samia [5 ]
Bernard, Sophie [6 ,7 ]
Bretagne, Stephane [5 ,6 ]
Thieblemont, Catherine [6 ,7 ]
Bagot, Martine [1 ,2 ,6 ]
de Masson, Adele [1 ,2 ,6 ]
机构
[1] Hop St Louis, AP HP, Serv Dermatol, Paris, France
[2] Hop St Louis, AP HP, INSERM, U976, Paris, France
[3] Hop St Louis, AP HP, Lab Pathol, Paris, France
[4] Hop St Louis, AP HP, Dept Malad Infect & Trop, Paris, France
[5] Hop St Louis, AP HP, Lab Parasitol, Paris, France
[6] Univ Paris, Paris, France
[7] Hop St Louis, AP HP, Serv Hematooncol, Paris, France
关键词
diagnostic challenge; lymphoma; negative HIV status; visceral leishmaniasis;
D O I
10.1097/MD.0000000000022787
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Non-HIV-related visceral leishmaniasis (VL) is becoming increasingly prevalent in nontropical countries because of the increasing number of patients with chronic diseases and the development of immune-modulating drugs. Patient concerns: Case 1 is a 60-year-old male patient of Senegalese origin presented with weight loss, lymphadenopathy, anemia, and elevated lactate dehydrogenases. Case 2 is a 46-year-old male patient of Algerian origin, with a negative HIV serology presented with cutaneous lesions. Diagnosis: Patient 1: The diagnosis of stage IV lymphocytic lymphoma (LL) was confirmed by an inguinal nodal biopsy in 2013. Patient 2: The diagnosis of T-cell lymphoma was made in 2003. Interventions: Patient 1 received 5 cycles of bendamustine and rituximab followed by a complete remission. Patient 2 was initially treated with >10 different treatments followed by 8 different chemotherapy regimens due to the disease progression. Outcomes: Patient 1: In 2017, after a follow-up of 4 years, the patient presented with fever, lymphadenopathy, splenomegaly, and pancytopenia in the setting of hemophagocytic syndrome. The initial diagnosis was a relapse of lymphoma and the patient was treated with ibrutinib. His status worsened, and Leishmania DNA was detected by polymerase chain reaction (PCR) on the blood and bone marrow aspirates. Ibrutinib was stopped. Amphotericin B treatment induced a complete clinical remission and clearance of Leishmania DNA from the blood. Patient 2: In 2017, after a follow-up of 14 years, the patient presented with fever, lymphadenopathy, hepatosplenomegaly, pancytopenia with hemophagocytic syndrome, and an increase in the tumor skin lesions. A skin biopsy was taken from the face and the patient. A careful reexamination of the skin biopsy revealed the presence of Leishmania bodies. He was treated with 40 mg/kg liposomal amphotericin B leading to a regression of the clinical symptoms and negativation of the blood PCR. Conclusions: This case study shows that VL may be a diagnostic challenge in patients with lymphoma. Reactivation or primary infection should be considered in the differential diagnosis. The purpose of this study is to remind clinicians to think of VL in patients with systemic symptoms that could be misdiagnosed as a progression of the underlying lymphoma.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature
    Basset, D
    Faraut, F
    Marty, P
    Dereure, J
    Rosenthal, E
    Mary, C
    Pratlong, F
    Lachaud, L
    Bastien, P
    Dedet, JP
    MICROBES AND INFECTION, 2005, 7 (13) : 1370 - 1375
  • [22] Nanoparticles for the treatment of visceral leishmaniasis: review
    de Santana, Natalia Silva
    de Siqueira, Luciana Betzler de Oliveira
    do Nascimento, Tatielle
    Santos-Oliveira, Ralph
    Matos, Ana Paula dos Santos
    Ricci-Junior, Eduardo
    JOURNAL OF NANOPARTICLE RESEARCH, 2023, 25 (02)
  • [23] Nanoparticles for the treatment of visceral leishmaniasis: review
    Natália Silva de Santana
    Luciana Betzler de Oliveira de Siqueira
    Tatielle do Nascimento
    Ralph Santos-Oliveira
    Ana Paula dos Santos Matos
    Eduardo Ricci-Júnior
    Journal of Nanoparticle Research, 2023, 25
  • [24] NEWER DRUGS FOR VISCERAL LEISHMANIASIS: A REVIEW
    Pandey, Krishna
    Singh, Dharmendra
    Bimal, Sanjiva
    Rabidas, Vidyanand
    Murti, Krishna
    Lal, Chadrashekhar
    Das, P.
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2014, 10 (02) : 68 - 70
  • [25] Visceral Leishmaniasis and Glomerulonephritis: A Case Report
    Alwazzeh, Marwan Jabr
    Alhashimalsayed, Zaki Hajji
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2019, 7 (01): : 40 - 43
  • [26] Visceral leishmaniasis in pregnancy: a case report
    Caldas, AJM
    Costa, JML
    Gama, MEA
    Ramos, EAG
    Barral, A
    ACTA TROPICA, 2003, 88 (01) : 39 - 43
  • [27] Decentralized control of human visceral leishmaniasis in endemic urban areas of Brazil: A literature review
    Menon S.S.
    Rossi R.
    Nshimyumukiza L.
    Zinszer K.
    Tropical Medicine and Health, 44 (1)
  • [28] HHV8-unrelated primary effusion lymphoma: Two case reports and a review of literature
    Kendall, Ryan W.
    Thompson, Ricky A.
    Garwacki, Christopher P.
    Skarbnik, Alan Z.
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2021, 4
  • [29] A Case of Oesophageal Leishmaniasis Indicating Visceral Leishmaniasis in a Patient with AIDS
    S. Sollima
    M. Pizzuto
    S. Bonetto
    L. Ravasio
    A. Tosoni
    L. Vago
    M. Corbellino
    S. Antinori
    European Journal of Clinical Microbiology and Infectious Diseases, 1999, 18 : 752 - 755
  • [30] Hemophagocytic lymphohistiocytosis secondary to visceral leishmaniasis in children: case report and systematic review
    Chen, Zhu
    Gao, Yi
    Zhang, Chaoyong
    Mao, Junwen
    FRONTIERS IN PEDIATRICS, 2025, 13